컨텐츠로 이동
Advances in biology and therapy of multiple myeloma. / Volume 2, Translational and clinical research 해당 항목을 미리보기
닫기해당 항목을 미리보기
확인중입니다…

Advances in biology and therapy of multiple myeloma. / Volume 2, Translational and clinical research

저자: Nikhil C Munshi; Kenneth C Anderson
출판사: New York ; London : Springer, ©2013.
판/형식:   전자도서 : 문서 : 영어모든 판과 형식 보기
데이터베이스:WorldCat
요약:
Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination  더 읽기…
평가:

(아무런 평가가 없습니다.) 0 리뷰와 함께 - 첫번째로 올려주세요.

주제
다음과 같습니다:

 

온라인으로 문서 찾기

이 항목에 대한 링크

도서관에서 사본 찾기

&AllPage.SpinnerRetrieving; 해당항목을 보유하고 있는 도서관을 찾는 중

상세정보

장르/형태: Electronic books
추가적인 물리적 형식: Print version:
Advances in biology and therapy of multiple myeloma. Volume 2, Translational and clinical research.
New York ; London : Springer, 2012
(OCoLC)817270653
자료 유형: 문서, 인터넷 자료
문서 형식: 인터넷 자원, 컴퓨터 파일
모든 저자 / 참여자: Nikhil C Munshi; Kenneth C Anderson
ISBN: 9781461452607 1461452600 1461452597 9781461452591
OCLC 번호: 821823520
메모: Includes index.
설명: 1 online resource.
내용: Myeloma Immune and Antibody Targets --
T Cell Responses in Myeloma / Ross Brown, P. Joy Ho, John Gibson, Douglas Joshua --
Novel Antigenic Targets for Immunotherapy in Myeloma / Qing Yi --
Antibody-Based Therapies in Multiple Myeloma / Yu-Tzu Tai --
Defining Multiple Myeloma as a Target for DNA Vaccines / Surinder S. Sahota, Natalia Savelyeva, Debora Joseph-Pietras, Niklas Zojer --
Harnessing Allogeneic Immunity for Anti-myeloma Response / Roberto Bellucci, Edwin P. Alyea --
Dendritic Cells and Peptide-Based Vaccine In Multiple Myeloma / Jooeun Bae, R. H. Prabhala, Nikhil C. Munshi --
New Agents --
Novel Proteasome Inhibitors / Robert Z. Orlowski --
Newer IMiDs / Abhishek Singla, Shaji Kumar. --
Novel Agents in Multiple Myeloma / Anuj Mahindra, Jacob Laubach, Constantine Mitsiades, Paul Richardson --
Early Combination Studies in Multiple Myeloma / Alessandra Larocca, Antonio Palumbo --
The Effect of Novel Anti-myeloma Agents on Bone Metabolism / Evangelos Terpos. T cell responses in myeloma --
Novel antigenic targets for immunotherapy in myeloma --
Antibody-based therapies in Multiple Myeloma --
Defining multiple myeloma as a target for DNA gene fusion vaccines --
Harnessing allogeneic immunity for anti-myeloma response --
Dendritic cell and peptide-based vaccination in myeloma --
New Proteasome inhibitors --
Newer Imids --
New agents in myeloma --
Early Combination Studies in MM --
The effect of novel antimyeloma agents on bone metabolism --
Index.\
다른 제목 Translational and clinical research
책임: edited by Nikhil C. Munshi, Kenneth C. Anderson.

초록:

This volume focuses on the biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel  더 읽기…

리뷰

사용자-기여 리뷰
GoodReads 리뷰 가져오는 중…
DOGObooks 리뷰를 가지고 오는 중…

태그

첫번째 되기

유사 항목

관련 주제:(6)

이 항목을 가지고 있는 사용자 목록 (1)

요청하신 것을 확인하기

이 항목을 이미 요청하셨을 수도 있습니다. 만약 이 요청을 계속해서 진행하시려면 Ok을 선택하세요.

링크된 데이터


<http://www.worldcat.org/oclc/821823520>
library:oclcnum"821823520"
library:placeOfPublication
library:placeOfPublication
library:placeOfPublication
rdf:typeschema:Book
rdf:typeschema:MediaObject
rdf:valueUnknown value: dct
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:alternateName"Translational and clinical research"
schema:bookFormatschema:EBook
schema:contributor
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:description"Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in multiple myeloma focusing on the development of molecularly-based novel targeted single-agent and combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. This volume will focus on biology of multiple myeloma, especially on oncogenomic changes, cell signaling pathways and intermediate molecules that are being investigated for development of novel therapies. The book will present newer developments, providing an emphasis on basic science, as well as its significant clinical impact."
schema:description"T cell responses in myeloma -- Novel antigenic targets for immunotherapy in myeloma -- Antibody-based therapies in Multiple Myeloma -- Defining multiple myeloma as a target for DNA gene fusion vaccines -- Harnessing allogeneic immunity for anti-myeloma response -- Dendritic cell and peptide-based vaccination in myeloma -- New Proteasome inhibitors -- Newer Imids -- New agents in myeloma -- Early Combination Studies in MM -- The effect of novel antimyeloma agents on bone metabolism -- Index.\"
schema:exampleOfWork<http://worldcat.org/entity/work/id/2022960558>
schema:genre"Electronic books"
schema:inLanguage"en"
schema:name"Advances in biology and therapy of multiple myeloma. Volume 2, Translational and clinical research"
schema:publication
schema:publisher
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=523058>
schema:url<http://site.ebrary.com/id/10634854>
schema:url<http://lib.myilibrary.com?id=424647>
schema:url
schema:workExample
schema:workExample
schema:workExample
wdrs:describedby

Content-negotiable representations

윈도우 닫기

WorldCat에 로그인 하십시오 

계정이 없으세요? 아주 간단한 절차를 통하여 무료 계정을 만드실 수 있습니다.